| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 11/19/2008 | CN100434421C Substituted propane-1,3-diamine derivatives and the pharmaceutical use |
| 11/19/2008 | CN100434114C Heath caring pillow of ganoderma lucidum |
| 11/19/2008 | CN100434104C Spleen tonifying tea |
| 11/19/2008 | CN100434100C Medicine, food used article for preventing and curing chronic diarrhoea and method for producing the same |
| 11/19/2008 | CN100434094C Medication for curing hepatic fibrosis and hepatic cirrhosis, and prepartion method |
| 11/19/2008 | CN100434090C Alginic nutrient capsules and preparation thereof |
| 11/19/2008 | CN100434075C Usage of caffeine and its analogue in resistance of hepatitis B replication and use thereof in preparation of medicament for treating viral hepatitis |
| 11/19/2008 | CN100434073C Use of chloride 13-hexyl berberine in preparation of medicine for treating peptic ulcer and bacteriological gastroenteritis |
| 11/19/2008 | CN100433991C Method for producing nutrition additive, additive and its use |
| 11/18/2008 | US7453010 trans-N-{5-[((2S)-3-{[4-(1,1'-Biphenyl-4-yl)cyclohexyl]amino}-2-hydroxypropyl)oxy]-2-hydroxyphenyl}methanesulfonamide; beta 3 receptor agonists; antiinflammtory agent; irritable bowel syndrome; obesity, diabeties, glaucoma, dysmenorrheal, depression, urinary incontinence, lipolysis or cicatrizing |
| 11/18/2008 | US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/18/2008 | US7452908 Amide derivatives |
| 11/18/2008 | US7452907 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 11/18/2008 | US7452905 Phenylalanine derivatives |
| 11/18/2008 | US7452904 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 11/18/2008 | US7452884 Methods for inhibiting angiogenesis |
| 11/18/2008 | US7452877 Irritable bowel disorders; controlling permeability of intestine tissue ; anticholinergic agent |
| 11/18/2008 | US7452723 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 11/18/2008 | US7452706 Recombinant bacterial phytases and uses thereof |
| 11/18/2008 | US7452535 Methods of treatment using CTLA-4 antibodies |
| 11/18/2008 | CA2440222C Triazolopyridines as anti-inflammatory agents |
| 11/18/2008 | CA2422379C Pyrazole compounds useful as protein kinase inhibitors |
| 11/18/2008 | CA2383222C Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 11/18/2008 | CA2381219C Monomeric protein of the tgf-beta family |
| 11/18/2008 | CA2365254C Treatment for dentin sensitivity with aqueous dispersions of hydrophobe-co-hydrophile copolymers |
| 11/18/2008 | CA2359640C Topical sprays |
| 11/18/2008 | CA2352275C Il-5 inhibiting 6-azauracil derivatives |
| 11/18/2008 | CA2343116C Methods and compositions for increasing intestinal absorption of fats |
| 11/18/2008 | CA2320822C Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 11/18/2008 | CA2318184C Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative as selective endothelin antagonists |
| 11/18/2008 | CA2249361C Enhancement of microbial colonisation of the gastrointestinal tract |
| 11/18/2008 | CA2107884C Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 11/13/2008 | WO2008136865A2 (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs |
| 11/13/2008 | WO2008136397A1 Composition for prevention and/or treatment of peptic ulcer |
| 11/13/2008 | WO2008136382A1 Bicyclic compound and pharmaceutical use thereof |
| 11/13/2008 | WO2008136377A1 Bicyclic heterocyclic compound |
| 11/13/2008 | WO2008136331A1 BRANCHED α-GLUCAN, α-GLUCOSYLTRANSFERASE PRODUCING THE SAME, METHOD FOR PRODUCING THE SAME AND USE THEREOF |
| 11/13/2008 | WO2008135115A2 Novel pharmaceutical composition for use as a laxative |
| 11/13/2008 | WO2008134932A1 Use of a vegetable drug composition in the manufacturing of a pharmaceutical preparation for the treatment of portal hypertension caused by hepatocirrhosis |
| 11/13/2008 | WO2008102145A3 Process for the preparation of esomeprazole magnesium dihydrate |
| 11/13/2008 | WO2008100547A3 Compositions comprising lamiridosin, iridoids or derivatives thereof for treatment of hepatitis c or hepatitis b |
| 11/13/2008 | WO2008099186A8 Heterocyclic derivatives as m3 muscarinic receptors |
| 11/13/2008 | WO2007145563A8 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor |
| 11/13/2008 | US20080281092 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 11/13/2008 | US20080280967 Antiarthritic agents; antiinflammatory agents; inflammatory bowel disorders; graft verses host disease; antiulcer agents; skin disorders; respiratory system disorders; anticancer agents |
| 11/13/2008 | US20080280944 Sleep disorders; administering a potassium channel moderator |
| 11/13/2008 | US20080280941 8-Phenoxy-Gamma Carboline Derivatives |
| 11/13/2008 | US20080280932 Synergistic mixture of inosine monophosphate dehydrogenasr inhibitor and hydroxy-3-methylglutaryl coenzyme a reductase inhibitor; low dosage; transplant rejection therapy, atherosclerosis, cardiovascular disorders, lupus, irritable bowel disorders, Crohn'd disease, antidiabetic agents, rheumatic diseases |
| 11/13/2008 | US20080280926 Phosphodiesterase Inhibitors |
| 11/13/2008 | US20080280918 phosphodiesterase enzyme inhibitor; 4-[(3-chlorophenyl)amino]-2-ethyl-5-(1-hydroxyethyl)-6-phenylpyridazin-3(2H)-one; potent antiinflammatory agent; asthma, atopic dermatitis, psoriasis, chronic obstructive pulmonary disease, rheumatoid arthritis, irritable bowel disease |
| 11/13/2008 | US20080280914 Intravenous Formulations of Pde Inhibitors |
| 11/13/2008 | US20080280913 dipeptidyl-peptidase IV (DPP-IV) inhibitors such as 5,5,6,6,8,8-d6-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine; increasing hormone glucagon-like peptide levels; pharmacokinetics; side effect reduction |
| 11/13/2008 | US20080280909 New phenylalanine derivatives |
| 11/13/2008 | US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus |
| 11/13/2008 | US20080280852 Composition Containing Fermentable Polysaccharides |
| 11/13/2008 | US20080280827 peptide(s) capable of inhibiting the TGF- beta activation reaction. The present invention provides a peptide consisting of 11 to 50 amino acid residues, which comprises an amino acid sequence Gln-Ile-Leu-Ser-X1-X2-X3-X4-Ala-Ser-Pro (SEQ ID NO: 1) wherein each of X1 to X4 independently represents |
| 11/13/2008 | US20080280308 G protein coupled receptor signaling modulation |
| 11/13/2008 | US20080279932 Vildagliptin salt; in mixture with therapeutic agents such as antidiabetic agents; antilipemic agents; obesity; appetite control; hypotensive agents; cholesterol absorption moderators; anticoagulants; estrogen receptor moderators; transferring across blood-brain barrier |
| 11/13/2008 | US20080279883 Ingestible Malodor Eliminator for Animals |
| 11/13/2008 | US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof |
| 11/13/2008 | US20080276568 Building structure and components thereof |
| 11/13/2008 | CA2685684A1 Use of a vegetable drug composition in the manufacturing of a pharmaceutical preparation for the treatment of portal hypertension caused by hepatocirrhosis |
| 11/13/2008 | CA2684813A1 New pharmaceutical composition for use as a laxative |
| 11/13/2008 | CA2684703A1 Bicyclic compound and pharmaceutical use thereof |
| 11/12/2008 | EP1990427A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 11/12/2008 | EP1990343A2 Azaindoles |
| 11/12/2008 | EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators |
| 11/12/2008 | EP1990056A1 Tooth root formation promoter and method for promotion of tooth root formation |
| 11/12/2008 | EP1988916A1 Methods and agents for reducing oxidative stress |
| 11/12/2008 | EP1988892A2 Modulators of muscarinic receptors |
| 11/12/2008 | EP1988785A1 Process for promoting overall health of an animal |
| 11/12/2008 | EP1259615B1 Antibodies against eotaxin and their use |
| 11/12/2008 | EP1147179B1 Human liver progenitors |
| 11/12/2008 | EP1014969B1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces |
| 11/12/2008 | CN101304982A Process for the preparation of benzotriazepine derivatives |
| 11/12/2008 | CN101304979A Quinazoline derivative and pharmaceutical |
| 11/12/2008 | CN101304970A Amorphous form of 1,2-dihydropyridine compound |
| 11/12/2008 | CN101304751A Composition for improving intestinal flora |
| 11/12/2008 | CN101302515A Human antibodies that bind human TNF(alpha) |
| 11/12/2008 | CN101302469A Fleece-flower root wine |
| 11/12/2008 | CN101302468A Black-bone chicken sticky rice sweet wine and preparation thereof |
| 11/12/2008 | CN101302467A Tuckahoe wine |
| 11/12/2008 | CN101302212A Preparation and use of silybum marianum di-partial succinate and salt thereof |
| 11/12/2008 | CN101301467A Uses of BMP-7 in preparing medicament for preventing and/or treating liver fibrosis |
| 11/12/2008 | CN101301451A Chinese medicine for treating liver disease |
| 11/12/2008 | CN101301441A Formulation of Chinese herbal medicine oral liquid and cold tea for treating recurrent mouth ulcer |
| 11/12/2008 | CN101301439A Use of frying millet in internal medicine pharmacy and use method |
| 11/12/2008 | CN101301438A Wine companion for promoting digestion, protecting liver and preventing alcoholism |
| 11/12/2008 | CN101301433A Oral Chinese medicine for treating hypotonia constipation |
| 11/12/2008 | CN101301409A Oral Chinese medicine for treating gastric ulcer with haematemesis |
| 11/12/2008 | CN101301401A Camellia effective ingredients and extracting method and use thereof |
| 11/12/2008 | CN101301396A Medicament for treating oral ulcer of children and preparation thereof |
| 11/12/2008 | CN101301391A Chinese herbal medicine oral liquid cold tea formulation for treating damp-heat viral hepatitis b |
| 11/12/2008 | CN101301386A Oral liquid of Wuqingtongti and preparation thereof |
| 11/12/2008 | CN101301382A Externally used Chinese medicine for treating viral hepatitis jaundice and preparation thereof |
| 11/12/2008 | CN101301380A Chinese medicinal compound formulation for treating ulcerative colitis |
| 11/12/2008 | CN101301375A Decoction for treating intestinal obstruction |
| 11/12/2008 | CN101301366A Chinese medicinal composition for treating toothache and preparation thereof |
| 11/12/2008 | CN101301365A Chinese and western compound medicament composition for treating bacterial enteritis of aquatic livestock |
| 11/12/2008 | CN101301364A Externally used Chinese medicine for treating cirrhosis ascites and preparation thereof |